Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Maureen Okam
ResearcherPublications, citations & collaboration network
Maureen Okam is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 22 works, 571 citations, an h-index of 10 and an i10-index of 10.
22
Works
571
Citations
10
h-index
10
i10-index
IDs:OpenAlex
How has Maureen Okam's publication output changed over time?
ScholarIQpublication output · 2011–2017
Output declined50% over the shown period — from 2 works in 2011 to 1 in 2017.
2
3
1
1
2
1
201120122013201420152017
What are the most-cited papers on Maureen Okam?
ScholarIQmost cited works
Iron Supplementation, Response in Iron-Deficiency Anemia: Analysis of Five Trials
Maureen Okam, Todd A. Koch, Minh‐Ha Tran
The American Journal of Medicine. 2017102 Citations
Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson
Joshua J. Field, Gene Lin, Maureen Okam, Elaine M. Majerus, Jeffrey R. Keefer, Onyinye Onyekwere, Ainsley Ross, Federico Campigotto, Donna Neuberg, Joel Linden, David G. Nathan
Blood. 2013100 CitationsOPEN ACCESS
Comparative rates of adverse events with different formulations of intravenous iron
Maureen Okam, Elyse Mandell, Nathanael D. Hevelone, Wentz Rachel, Ainsley Ross, Gregory A. Abel
American Journal of Hematology. 201258 CitationsOPEN ACCESS
Refining the value of secretory phospholipase <scp>A</scp><sub>2</sub> as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (<scp>PROACTIVE</scp>)
Lori Styles, Carrie Wager, Richard Labotka, Kim Smith‐Whitley, Alexis A. Thompson, Peter A. Lane, Lillian E.C. McMahon, R Eric Miller, Susan D. Roseff, Rathi V. Iyer, Lewis L. Hsu, Oswaldo Castro, Kenneth I. Ataga, Onyinye Onyekwere, Maureen Okam, Rita Bellevue, Scott T. Miller
S153015021. 201251 CitationsOPEN ACCESS
Related on ScholarIQ
Anemia in Pregnancy
Paper
Iron Supplementation, Response in Iron-Deficiency Anemia: Analysis of Five Trials
Paper
Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson
Paper
Comparative rates of adverse events with different formulations of intravenous iron
Paper
Refining the value of secretory phospholipase <scp>A</scp><sub>2</sub> as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (<scp>PROACTIVE</scp>)
Paper
National Trends in Hospitalizations for Sickle Cell Disease in the United States Following the FDA Approval of Hydroxyurea, 1998–2008
Paper